Estudio VARIAR: VAloración de la eficacia y seguridad a corto plazo en artritis reumatoide del uso de RItuximab comparado con Antagonistas del factor de necrosis tumoral alfa en segunda línea terapéutica en pacientes con artritis reumatoide Refractarios a un primer antagonista del factor de necrosis tumoral alfa

Statistics

Original breve

VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist

Vicenç Torrente-Segarraa,

Corresponding author

vtorrente@hsjdbcn.org
vicente.torrentesegarra@sanitatintegral.org

Autor para correspondencia.

, Asunción Acosta Pereirab, Rosa Morlac, José Miguel Ruizd, Teresa Clavaguerae, Ramon Figulsa, Hector Corominasa, Carme Gelib, Rosa Rosellóf, Juan José de Agustíng, Cayetano Alegreg, Carolina Pérezh, Angel Garcíai, Arturo Rodríguez de la Sernab

a Hospital General Hospitalet-Moisès Broggi, Sant Joan Despí, Barcelona, España

b Hospital Santa Creu i Sant Pau, Barcelona, España

c Hospital del Vendrell, El Vendrell, Tarragona, España

d Hospital de Viladecans, Viladecans, Barcelona, España

e Hospital de Palamós, Palamós, Girona, España

f Hospital de San Jorge, Huesca, España

g Hospital de la Vall d’Hebron, Barcelona, España

h Hospital de Mollet, Mollet del Vallès, Barcelona, España

i Hospital de Torrevieja, Torrevieja, Alicante, España

Read

8358

Times
was read the article

2821

Total PDF

5537

Total HTML

Share statistics

Article information

ISSN: 1699258X
Original language: Spanish

DOI:10.1016/j.reuma.2015.11.019

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 May	10	5	15
2024 April	62	28	90
2024 March	56	32	88
2024 February	42	25	67
2024 January	26	15	41
2023 December	35	23	58
2023 November	37	25	62
2023 October	75	37	112
2023 September	62	31	93
2023 August	34	14	48
2023 July	42	36	78
2023 June	54	26	80
2023 May	50	24	74
2023 April	38	10	48
2023 March	81	24	105
2023 February	57	35	92
2023 January	37	14	51
2022 December	93	38	131
2022 November	69	42	111
2022 October	72	38	110
2022 September	44	24	68
2022 August	57	84	141
2022 July	33	80	113
2022 June	34	27	61
2022 May	41	38	79
2022 April	35	26	61
2022 March	47	46	93
2022 February	57	29	86
2022 January	40	35	75
2021 December	78	48	126
2021 November	36	33	69
2021 October	57	62	119
2021 September	50	42	92
2021 August	53	37	90
2021 July	78	29	107
2021 June	57	28	85
2021 May	67	54	121
2021 April	122	83	205
2021 March	70	40	110
2021 February	40	21	61
2021 January	43	34	77
2020 December	58	25	83
2020 November	46	22	68
2020 October	40	25	65
2020 September	52	29	81
2020 August	45	32	77
2020 July	34	28	62
2020 June	60	19	79
2020 May	58	35	93
2020 April	34	19	53
2020 March	40	11	51
2020 February	33	26	59
2020 January	50	21	71
2019 December	41	18	59
2019 November	38	21	59
2019 October	47	20	67
2019 September	76	27	103
2019 August	39	13	52
2019 July	43	21	64
2019 June	69	18	87
2019 May	86	37	123
2019 April	47	31	78
2019 March	37	24	61
2019 February	34	21	55
2019 January	46	31	77
2018 December	133	53	186
2018 November	230	16	246
2018 October	198	15	213
2018 September	49	9	58
2018 August	35	9	44
2018 July	24	10	34
2018 May	5	0	5
2018 April	111	18	129
2018 March	59	16	75
2018 February	36	9	45
2018 January	22	19	41
2017 December	45	16	61
2017 November	30	20	50
2017 October	34	10	44
2017 September	47	24	71
2017 August	35	15	50
2017 July	45	32	77
2017 June	41	30	71
2017 May	67	34	101
2017 April	55	23	78
2017 March	48	37	85
2017 February	51	23	74
2017 January	255	68	323
2016 December	261	82	343
2016 November	208	114	322
2016 October	36	46	82
2016 September	15	42	57
2016 August	20	16	36
2016 July	18	19	37

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter